Bilateral Lower Leg Pruritus in a 70s Patient with Taut Skin and Remote Chemotherapy History
Given the bilateral lower leg distribution, taut skin appearance, and history of chemotherapy, this presentation raises concern for either scleroderma-spectrum disease, lymphoma-associated pruritus, or elderly xerosis with possible underlying systemic disease—you must pursue a systematic laboratory workup to exclude malignancy recurrence and systemic causes before attributing this to benign senile pruritus.
Most Likely Differential Diagnoses
The combination of taut skin with pruritus in the lower extremities is particularly concerning and narrows the differential significantly:
Primary Considerations:
- Scleroderma/systemic sclerosis (taut skin is a key feature)
- Lymphoma recurrence or late effect (given chemotherapy history 3 years ago)
- Bullous pemphigoid (can present with pruritus alone before blistering, especially in elderly) 1
- Chronic kidney disease with uremic pruritus
- Elderly pruritus with xerosis (though taut skin suggests more than simple dryness)
Essential Laboratory Workup
Based on British Association of Dermatologists guidelines for generalized pruritus without rash 1, order these investigations systematically:
First-Line (Mandatory) Labs:
- Complete blood count with differential - screen for lymphoma, polycythemia vera, eosinophilia 1
- Ferritin - iron deficiency commonly causes pruritus 1
- Comprehensive metabolic panel (urea, creatinine, electrolytes) - uremic pruritus 1
- Liver function tests - cholestatic pruritus 1
- Erythrocyte sedimentation rate or C-reactive protein 1
- Lactate dehydrogenase - elevated in lymphoma 1
Second-Line Labs (Based on Clinical Suspicion):
- Antinuclear antibodies (ANA) and anti-Scl-70 - for scleroderma given taut skin
- Skin biopsy with direct immunofluorescence - essential to rule out bullous pemphigoid, which can present with pruritus alone before visible blisters in elderly patients 1
- Chest X-ray - screen for lymphoma recurrence or solid tumor 1
- Hepatitis B and C serology - if liver enzymes abnormal
- Fasting glucose and HbA1c - diabetes-associated neuropathic pruritus
Consider if Initial Workup Negative:
- CT chest/abdomen/pelvis - if concern for malignancy recurrence persists 1
- JAK2 V617F mutation - if polycythemia vera suspected (elevated hemoglobin/hematocrit) 1
Critical Clinical Pitfalls
The taut skin is the key distinguishing feature here - this is NOT typical of simple elderly xerosis. The British guidelines specifically note that pruritus can be the sole presenting feature of bullous pemphigoid in the elderly, often misdiagnosed initially 1. Additionally, the chemotherapy history raises concern for:
- Late lymphoma recurrence - pruritus affects 25-35% of Hodgkin lymphoma patients and can precede other symptoms by months 2, 3
- Chemotherapy-induced scleroderma - certain agents can trigger fibrotic skin changes
- Paraneoplastic phenomenon from solid tumor recurrence 1
Immediate Management While Awaiting Results
Per guidelines for elderly pruritus 1:
- High-lipid content emollients applied liberally twice daily (strength of recommendation D)
- Topical corticosteroids (clobetasone butyrate) for at least 2 weeks to treat potential asteatotic eczema 1
- Avoid sedating antihistamines in elderly (increased dementia risk) 1
- Consider nonsedating antihistamines (fexofenadine 180mg or cetirizine 10mg) for symptomatic relief 1
When to Refer
Refer to dermatology urgently if:
- Skin biopsy shows bullous pemphigoid or cutaneous lymphoma
- Taut skin progresses or involves other body areas (rheumatology referral for scleroderma)
- No improvement after 2 weeks of emollients and topical steroids 1
Refer to hematology if:
- Abnormal CBC, elevated LDH, or JAK2 mutation positive 1
- History suggests lymphoma recurrence
The history of chemotherapy three years ago mandates you cannot dismiss this as simple senile pruritus - 20-30% of generalized pruritus cases have significant underlying systemic disease 1, and the taut skin appearance demands investigation for connective tissue disease or infiltrative processes.